{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:16:55Z","timestamp":1770059815341,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.reuma.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T10:13:09Z","timestamp":1319278389000},"page":"287-291","source":"Crossref","is-referenced-by-count":27,"title":["Hiperparatiroidismo: \u00bfprimario o secundario?"],"prefix":"10.1016","volume":"8","author":[{"given":"Isabel Mart\u00ednez","family":"Cordellat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2011.06.001_bib0005","series-title":"The parathyroid glands and metabolic bone disease","author":"Albright","year":"1984"},{"key":"10.1016\/j.reuma.2011.06.001_bib0010","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1210\/jc.2008-1305","article-title":"Time to reconsider current clinical decision paradigms?","volume":"93","author":"El-Hajj Fuleihan","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.001_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.reuma.2011.06.001_bib0020","first-page":"2","volume":"6","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.001_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.001_bib0030","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1210\/jc.81.10.3487","article-title":"Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"81","author":"Guo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.001_bib0035","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.reuma.2011.06.001_bib0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","article-title":"Nephrolithiasis and bone involvement in primary hyperparathyroidism","volume":"89","author":"Silverberg","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2011.06.001_bib0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"The risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: a controlled historical follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.reuma.2011.06.001_bib0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.beem.2003.08.001","article-title":"Disorders of calcium homeostasis","volume":"17","author":"Carmeliet","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.001_bib0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","article-title":"Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism","volume":"87","author":"Turken","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2011.06.001_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(94)90128-7","article-title":"Psychologic symptoms before and after parathyroid surgery","volume":"96","author":"Solomon","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2011.06.001_bib0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.reuma.2011.06.001_bib0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4158\/EP.11.3.197","article-title":"American College of Endocrinology and American Association of Clinical Endocrinologists position statement on patient safety and medical system errors in diabetes and endocrinology","volume":"11","author":"Bates","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.reuma.2011.06.001_bib0075","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism.","first-page":"302","article-title":"Primary hyperparathyroidism","author":"Silverberg","year":"2008"},{"key":"10.1016\/j.reuma.2011.06.001_bib0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.reuma.2011.06.001_bib0085","first-page":"N51","article-title":"Familiar benign hypocalcyiuc hypercalcemia","volume":"17","author":"Fuleiham","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.001_bib0090","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2007-0322","article-title":"Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familiar hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population","volume":"92","author":"Nissen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.001_bib0095","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2011.06.001_bib0100","series-title":"Principles of bone biology","first-page":"1031","article-title":"Familial benign hypocalciuric hypercalcemia and neonatal primary hyperparathyroidism","author":"El-Hajj Fuleihan","year":"2002"},{"key":"10.1016\/j.reuma.2011.06.001_bib0105","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Khan AA, Potts Jr JT, on behalf of the Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab. 2009;94:335\u20139.","DOI":"10.1210\/jc.2008-1763"},{"key":"10.1016\/j.reuma.2011.06.001_bib0110","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism.","first-page":"317","article-title":"Non parathyroid hypercalcemia","author":"Horwitz","year":"2008"},{"key":"10.1016\/j.reuma.2011.06.001_bib0115","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipien\u201d primary hyperparathyroidism: a \u201cforme frusta\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinology Metab"},{"key":"10.1016\/j.reuma.2011.06.001_bib0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","article-title":"Characterizacion of normocalcemic primary huperparathyroidism","volume":"117","author":"Tordjman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2011.06.001_bib0125","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterizacion of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin End Metab"},{"key":"10.1016\/j.reuma.2011.06.001_bib0130","volume":"30","author":"Brixen","year":"2006"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X11001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X11001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T07:28:56Z","timestamp":1543476536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X11001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1699258X11001793"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2011.06.001","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}